LIVE WEBINAR
Wednesday, May 14 | 2pm ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​

A winning market access strategy is pivotal to the success of any launch — which is especially true today, as therapeutics become even more complex and costly to bring to market. To complicate matters, the rapid evolution of biosimilars is intensifying access challenges and driving competitive pricing pressure.

In this webinar, we’ll share insights from a survey of 250 high-level stakeholders across the pharma industry into the state of patient access as it stands today. We’ll explore how brands are rethinking their market access strategies in response to the rise of biosimilars, as well as how they’re navigating regulatory and market shifts to position their commercialization strategies for success. You will learn:

• The most commonly cited challenges impeding patient access today
•  How the fast-growing biosimilars market is reshaping patient access
• What manufacturers can do to overcome market access hurdles

SPEAKERS

Steve Callahan
Senior Director of Advisory & Insights
MMIT

Hannah Baxter
Partner
The Dedham Group